Tai Chi Interventions on Physical Functions Among Older Adults

November 11, 2025 updated by: Weiyun Chen, University of Michigan

Feasibility and Effectiveness of a Multimodal Exercise Intervention on Physical Activity and Physical Functions in Low-Income Older Adults

This study examined the feasibility and effectiveness of a multimodal exercise intervention on an objective measure of physical activity (PA), and objective and subjective measures of physical functions among older adults living in a low-income senior housing complex.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study aimed to examine the feasibility and effectiveness of a multimodal exercise intervention on an objective measure of physical activity (PA), and objective and subjective measures of physical functions among older adults living in a low-income senior housing complex. 23 older adults (mean age = 80.17 ± 6.913 years) residing in a low-income senior housing complex voluntarily participated in an 8-week intervention. The feasibility of the study was assessed throughout the study period. Additionally, participants completed The Acceptability, Appropriateness, and Feasibility of the Intervention Questionnaire (AAF-IQ) after the intervention. The study outcomes, including physical activity and physical functions, were measured within two weeks before and after the intervention.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
27

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • School of Kinesiology, University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. age 65 years or above,
  2. able to walk for 10 feet without human assistance, a cane or walker was permitted,
  3. willing to wear an ActiGraph activity monitor for 7 days at baseline and post-intervention test,
  4. exercise safely as determined by their healthcare provider,
  5. complete the study tests and questionnaires,
  6. sign the informed consent,
  7. able and willing to comply with the requirements of the protocol.

Exclusion Criteria:

  1. having recent medical limitations including recent myocardial infarction, stroke, or physical limitations for exercises by completing the Physical Activity Readiness Questionnaire (PAR-Q),
  2. having 40 or higher body mass index (BMI) by self-reporting body weight and body height, inputting these into the computerized BMI calculator.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Combined multicomponent exercise and Tai Chi
This combined multicomponent exercise and Tai Chi intervention includes that participants attended one 45-minute multicomponent exercise group session and one 45-minute Tai Chi group session each week, along with self-practice for eight weeks.
Behavioral: Combined multicomponent exercise and Tai Chi
The combined multicomponent exercise and Tai Chi intervention includes that participants attended one 45-minute multicomponent exercise group session and one 45-minute Tai Chi group sessions along with self-practice each week, for eight weeks.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Weekly Physical Activity Minutes
Time Frame: Baseline test and post-intervention test (up to 3 months).
Weekly physical activity minutes were measured by having participants wear an ActiGraph activity monitor for seven consecutive days during waking hours, expect for bathing activities. The raw data were analyzed by using the ActiLife software.
Baseline test and post-intervention test (up to 3 months).
Short Physical Performance Battery (SPPB)-Repeated Chair Stand test.
Time Frame: Baseline test and post-intervention test (up to 3 months).
This test is used to measure low extremity strength.
Baseline test and post-intervention test (up to 3 months).
The Short Physical Performance Battery-Balance test.
Time Frame: Baseline and post-intervention test (Up to 3 months).
This test is used to measure balance.
Baseline and post-intervention test (Up to 3 months).

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Timed Up and Go Test
Time Frame: Baseline test and the post-intervention test (up to 3 months).
This test is used to measure gait speed.
Baseline test and the post-intervention test (up to 3 months).
The Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form
Time Frame: Baseline test and post-intervention test (up to 3 months).
This questionnaire is used to assess participants' perceived physical function.
Baseline test and post-intervention test (up to 3 months).
Assessing Feasibility, Acceptability, and Appropriateness of the Intervention Questionnaire
Time Frame: Post-intervention test (up to one week).
This questionnaire is used to assess the participant's views of feasibility, acceptability, and appropriateness of the intervention.
Post-intervention test (up to one week).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 27, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 14, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 23, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
October 19, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 11, 2025

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 14, 2025

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 14, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 11, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • HUM00267001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings